However, the lowest concentration of Dystrophin in DMD patients is only 5-fold higher than that in the lowest limit of quantification (LLOQ) [95,96], which is not detectable by immunoassay technology combining electrochemiluminescence and multiarray technology for detecting multiple proteins in a sample and Western blotting due to their low sensitivity. Here, DMD is linked to Duchenne muscular dystrophy.